Pharma Co. Hit With Investor Suit Over Sponsored Blog Posts
A CytRx Corp. stockholder filed a securities class action against the biopharmaceutical company in California federal court Wednesday, alleging it waged a blogging campaign to fraudulently inflate its stock price as...To view the full article, register now.
Already a subscriber? Click here to view full article